The UroScan's strategy will be leading provider of fast and reliable diagnostic tests for various diseases basing on urine examination. There is an increasing number of scientific reports suggesting the presence of multiple biomarkers in the urine. Although, there is still a lack of methods to use widely in healthcare.
UroScan is a biotechnological start-up that is designed for conducting R&D and implementation of new solutions in the diagnostic area. The company aims to develop tools that will make diagnostic easier, faster, and more affordable. UroScan Company will introduce portable devices for general urine examination and non-invasive methods for bladder cancer detection. Still, in further perspective, the Company will launch dedicated tests for chronic kidney disease and ovarian cancer. In the long term, the company will provide research and development to detect various types of cancer in urine.